Children’s Health Defense – by Megan Redshaw
Moderna will begin studying its COVID vaccine in pregnant women, according to a posting on ClinicalTrials.gov. The observational study, expected to begin July 22, will enroll about 1,000 females over age 18 who will be studied over a 21-month period.
Women who received a Moderna vaccine during the 28 days prior to their last menstrual period, or at any time during pregnancy, are eligible. Continue reading “Experts Warn of ‘Huge Risk’ as Moderna Launches COVID Vaccine Trials for Pregnant Women”